Evidence map›Paper›PMID 37670172›Full record

ArticleJournal of urban health : bulletin of the New York Academy of Medicine2023

Evaluating the Impact of Brave Technology Co-op's Novel Drug Overdose Detection and Response Devices in North America: a Retrospective Study.

Ralph Amuanyu Welwean, Oona Krieg, Gordon Casey, Erin Thompson, Dana Fleetham, Theresa Deering, Joseph G Rosen, Ju Nyeong Park

Abstract read
In one paragraph

Article in Journal of urban health : bulletin of the New York Academy of Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ralph Amuanyu WelweanDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI, USA. ralph_welwean@brown.edu.ORCID 0000-0003-3019-0549
Oona KriegBrave Technology Coop, Vancouver, British Columbia, Canada.
Gordon CaseyBrave Technology Coop, Vancouver, British Columbia, Canada.
Erin ThompsonHarm Reduction Innovation Lab, Rhode Island Hospital, Providence, RI, USA.
Dana FleethamBrave Technology Coop, Vancouver, British Columbia, Canada.
Theresa DeeringBrave Technology Coop, Vancouver, British Columbia, Canada.
Joseph G RosenDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Ju Nyeong ParkDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI, USA.

Funding

Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI Brandon David Lewis Marshall · 2018 to 2026
$23.4M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Viral Load Trajectories and Dynamics among People Living with HIV in Rakai, Uganda: A Mixed-Methods StudyF31MH126796 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ROSEN, JOSEPH GREGORY · 2021 to 2022
$79k
NIGMS NIH HHS P20 GM125507NIMH NIH HHS F31 MH126796NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

Assess the preliminary impact of Brave Technology Co-op's overdose detection devices that have been implemented in housing, medical, social service facilities, and several private settings in North America. Administrative data was collected by Brave on their Buttons and Sensors during several proof-of-concept projects and full installations in Canada and United States (US) between December 2018 and July 2022. Data analyzed provided insights on the number of overdoses detected and reversed (averted overdose deaths) using Brave Sensors and Buttons, along with other programmatic and session-specific indicators. Implementation of 486 Brave Buttons and 148 Brave Sensors in Canada has detected and prevented 108 overdose deaths (100 using Buttons and 8 using Sensors) whereas implementation of 170 Buttons in the US has averted 2 overdose deaths to date, with the potential to save many more lives. Brave's devices hold promise for increasing rates of overdose detection and preventing overdose deaths.

Indexed as

Drug OverdoseAnalgesics, OpioidCanadaHousingHumansNorth AmericaRetrospective StudiesUnited StatesAnalgesics, Opioid

Identifiers

PMID37670172
PMCPMC10618129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.